Nektar Therapeutics (NKTR) ownership: insiders 0% · institutions 77% · index and ETF funds 4% (13F 2026-03-31). Insider activity, 90 days: 8 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| FMR (Fidelity) | 4303188.00 | $309.61M | 12.6% | 2026-03-31 |
| BVF Inc/il | 2559595.00 | $184.16M | 7.5% | 2026-03-31 |
| Two Seas Capital LP | 1959178.00 | $140.96M | 5.7% | 2026-03-31 |
| Vanguard | 1476064.00 | $106.20M | 4.3% | 2026-03-31 |
| Two Sigma | 930741.00 | $66.97M | 2.7% | 2026-03-31 |
| Prosight Management, LP | 735000.00 | $52.88M | 2.2% | 2026-03-31 |
| BlackRock | 692650.00 | $49.84M | 2.0% | 2026-03-31 |
| Morgan Stanley | 659387.00 | $47.44M | 1.9% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-08-18 | |
| Sell | null | 2026-07-24 | |
| Sell | null | 2026-07-24 | |
| Sell | null | 2026-06-30 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 |
Back to NKTR overview · NKTR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.